(93) discovered that nerolidol can enhance FSH levels in DHEA-induced PCOS model SD rats, thereby regulating hormonal secretion disorders
Drugmakers argue the shortages are over and the FDA correctly relied on supply data, while compounders say the agency rushed its decision, ignored evidence of ongoing shortages, and used an improper legal process
Available from: (Accessed Mar, 2021)
Reducing inflammation: GLP-1s reduce systemic inflammation markers - relevant because chronic low-grade inflammation in PCOS disrupts ovarian function and compounds hormonal dysregulation
acknowledges the support of an Emmy Noether Award from the German Research Foundation (DFG, 467788900) and the Ministry of Culture and Science of the State of North Rhine-Westphalia (NRW-Nachwuchsgruppenprogramm)
TRPA1 sensitization during diabetic vascular impairment contributes to cold hypersensitivity in a mouse model of painful diabetic peripheral neuropathy